Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European Cooperative Acute Stroke Study

Stroke

Volumn 28, Issue 5, 1997, Pages 957-960

  Larrue, Vincent ^c   Von Kummer, Rüdiger ^d   Del Zoppo, Gregory ^a   Bluhmki, Erich ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c CHU RANGUEIL   (France)

^d NONE

Author keywords

cerebral hemorrhage; risk factors; stroke, acute; thrombolytic therapy

Indexed keywords

ALTEPLASE;

ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EUROPE; FIBRINOLYTIC THERAPY; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STROKE;

EID: 0030950928     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.5.957     Document Type: Article

References (25)

1. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici MG, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
2. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
3. Hommel M, Boissel JP, Cornu C, Boutitie F, Lees KR, Besson G, Leys D, Amarenco P, Bogaert M, for the MAST Study Group. Termination of trial of streptokinase in severe acute ischemic stroke. Lancet. 1995;345:57. Letter.
4. MAST-I Group. Randomised controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischemic stroke. Lancet. 1995;346:1509-1514.
5. Donnan GA, Davies SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR. Trials of streptokinase in severe acute ischemic stroke. Lancet. 1995;345: 578-579.
6. del Zoppo GJ. Acute stroke: on the threshold of a therapy? N Engl J Med. 1995;333:1632-1633.
7. Toni D, Fiorelli M, Bastianello S, Saccheti ML, Sette G, Argentino C, Montinaro E, Bozzao L. Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology. 1996;46:341-345.
8. Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadoshima S, Fujishima M, Omae T. Hemorrhagic transformation in cerebral embolism. Stroke. 1989;20:598-601.
9. Hornig CR, Dorndorf W, Agnoli AL. Hemorrhagic cerebral infarction: a prospective study. Stroke. 1986;17:179-185.
10. Bozzao L, Angcloni U, Bastianello S, Fantozzi LM, Pierallini A, Fieschi C. Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol. 1991;12:1115-1121.
11. Horowitz SH, Zito JL, Donnarumma R, Patel M, Alvir J. Computed tomographic-angiographic findings within the first five hours of cerebral infarction. Stroke. 1991;22:1245-1253.
12. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
13. Boysen G, Hacke W. European Cooperative Acute Stroke Study (ECASS): study design and progress report. Eur J Neurol. 1995;1: 213-219.
14. Wolpert S, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ, and the rT-PA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 1993;14:3-13.
15. Pessin M, del Zoppo GJ, Estol C. Thrombolytic agents in the treatment of stroke. Clin Neuropharmacol. 1990;13:271-289.
16. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: background and study protocol. Stroke. 1985;16:885-890.
17. von Kummer R, Meyding-Lamade V, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol. 1994;15:9-15.
18. Branston NM, Bell BA, Hunstock A, Symon L. Time and flow as factors in the formation of postischemic edema in primate cortex. In: Cervos-Navarro J, Ferszt R, eds. Advances in Neurology, Vol 28: Brain Edema. New York, NY: Raven Press Publishers; 1980: 291-298.
19. Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke. 1994;25:298-303.
20. Simoons ML, Maggioni AP, Knatterud G, Leimberger JD, De Jaegere P, van Domburg R, Boersma E, Franzosi MG, Califf R, Schroder R, Braunwald E. Individual risk assessment for intracranial hemorrhage during thrombolytic therapy. Lancet. 1993;324: 1523-1528.
21. Sloan MA, Price TR, Petito CK, Randall AMY, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F, Babb J, Herman M, Roberts WC, Sopko G, Bovill E, Forman S, Knatterud GL, for the TIMI Investigators. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II pilot and randomized clinical trial combined experience. Neurology. 1995;45:649-658.
22. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar hemorrhage in the elderly. J Neurol Sci. 1993;116:135-141.
23. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22:983-988.
24. Levy DE, Brott TG, Haley EC, Marier J. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke. 1994;25: 291-297.
25. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke. 1995;26:2219-2221.